Allen & Overy advises Rexam on sale of its healthcare business
Allen & Overy has advised Rexam, a global beverage can maker, on the sale of the bulk of its healthcare business to Montagu Private Equity for $805m (£494m).
In this transaction, Rexam is selling its pharmaceutical devices and prescription retail packaging divisions, returning £450m in cash to shareholders.
The transaction is subject to consultation with various European works councils, is conditional on the necessary regulatory approvals and is subject to certain adjustments at completion. The transaction is expected to complete around the middle of 2014.
News from Allen & Overy
News from The Lawyer
Briefings from Allen & Overy
Practically every aspect of financial law is regulated and controlled to the highest degree. Not so state insolvency.
The purpose of this paper is to examine the impact of a sovereign state restructuring on credit default swaps.
Analysis from The Lawyer
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe
Why has Herbert Smith Freehills (HSF) decided to walk away from the Singapore qualifying foreign law practice (QFLP) scheme?